Temporal Targeting of Tumour cells and Neovasculature with a Nanoscale
Delivery System

S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe and & R. Sasisekharan Nature 2005; 436: 568

Preclinical Efficacy of the Camptothecin-Polymer Conjugate
IT-101 in Multiple Cancer Models
T. Schluep, J. Hwang, J. Cheng, J. Heidel, D. Bartlett, B.Hollister, and M. E. Davis
Clinical Cancer Research 2006; 12(5) 1606

Pharmacokinetics and Biodistribution of the Camptothecin–polymer Conjugate IT-101 in Rats and Tumor-bearing Mice
T. Schluep, J. Cheng, K. Khin and M. E. Davis
Cancer Chemother. Pharmacol. 2006; 57: 654

α-Methylprednisolone Conjugated Cyclodextrin Polymer-based Nanoparticles for Rheumatoid Arthritis Therapy
J. Hwang, K. Rodgers, J. Oliver and T. Schluep
Int J Nanomedicine. 2008; 3(3): 359

Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft Models
T. Numbenjapon, J. Wang, D. Colcher, T. Schluep, M. E. Davis, J. Duringer, L. Kretzner, Y. Yen, S. J. Forman and A. Raubitschek
Clinical Cancer Research 2009; 15 (13) 4366

Design and development of IT-101, a Cyclodextrin-containing Polymer Conjugate of Camptothecin
M. E. Davis
Advanced Drug Delivery Reviews 2009; 61(13) 1189

Pharmacokinetics and Tumor Dynamics of the Nanoparticle IT-101 from PET Imaging and Tumor Histological Measurements
T. Schluep, J. Hwang, I. Hildebrandt, J. Czernin, C. Choi, Alabi, B. Mack and M. E. Davis
PNAS 2009; 106 (27) 11394